Cargando…
The role of oral methotrexate as a steroid sparing agent in refractory eosinophilic asthma
The use of oral methotrexate for refractory eosinophilic asthma in a tertiary asthma referral centre, Glenfield Hospital, Leicester, was evaluated between January 2006 and December 2014. The patients (n = 61) were carefully phenotyped at baseline with markers of airway inflammation. In addition, a s...
Autores principales: | Bilocca, David, Hargadon, B, Pavord, ID, Green, RH, Brightling, CE, Bradding, P, Wardlaw, AJ, Martin, N, Murphy, AC, Siddiqui, S |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5802657/ https://www.ncbi.nlm.nih.gov/pubmed/28569072 http://dx.doi.org/10.1177/1479972317709650 |
Ejemplares similares
-
Body Mass and Fat Mass in Refractory Asthma: An Observational 1 Year Follow-Up Study
por: Bafadhel, Mona, et al.
Publicado: (2010) -
A randomised controlled trial of small particle inhaled steroids in refractory eosinophilic asthma (SPIRA)
por: Hodgson, David, et al.
Publicado: (2015) -
Quantitative analysis of high-resolution computed tomography scans in severe asthma subphenotypes
por: Gupta, Sumit, et al.
Publicado: (2010) -
IL-13 expression by blood T cells and not eosinophils is increased in asthma compared to non-asthmatic eosinophilic bronchitis
por: Siddiqui, Salman, et al.
Publicado: (2009) -
Eosinophilic Fasciitis Responds Well to Steroids and Methotrexate
por: Mahdi, Asmaa Sabr, et al.
Publicado: (2019)